Entheon Biomedical (TSE:ENBI) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Canadian biotech firm Entheon Biomedical is launching a private placement financing to raise up to CDN$300,000 by issuing 3 million units, each consisting of a common share and a warrant. The proceeds will be used for general working capital, providing potential growth opportunities for the company focused on addiction treatment.
For further insights into TSE:ENBI stock, check out TipRanks’ Stock Analysis page.
